Inhaled Bordetella pertussis vaccine decreases airway responsiveness in guinea pigs.
Bordetella pertussis (BP) has been used as adjuvant for experimental animal immunization, but its effects on airway responsiveness are uncertain. Three groups of guinea pigs were used: animals with a single exposure to inhaled BP vaccine (strain 134, total dose 1.24 x 10(12) germs), animals submitted to a sensitization procedure through inhalation of ovalbumin plus BP, and healthy control animals. Four weeks after inhalation of BP or after the beginning of sensitization, dose- or concentration-response curves to histamine were constructed in vivo and in vitro (tracheal and parenchymal preparations). We found that BP alone produced lower responses to histamine than control guinea pigs in vivo (insufflation pressure, p = 0.0003) and in tracheal tissues (p = 0.04), but not in parenchymal preparations. Sensitization did not modify the responsiveness compared with their respective controls. These results suggest that some BP component(s), probably pertussis toxin, causes a long lasting airway hyporesponsiveness in guinea pigs.
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000280:Administration, Inhalation; D000818:Animals; D001886:Bordetella pertussis / Q000276:immunology*; D016535:Bronchial Hyperreactivity / Q000209:etiology / Q000503:physiopathology*; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007114:Immunization; D008297:Male; D010567:Pertussis Vaccine / Q000008:administration & dosage* / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D010567:Pertussis Vaccine; D006632:Histamine